Skip to Main Content

Paper Details

Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021.
JCO Oncol Pract
0
2023
Author NameAffiliation
Christine Y LuHarvard Pilgrim Healthcare Institute and Harvard Medical School
Christine Y LuSydney Pharmacy School, The University of Sydney
Christine Y LuKolling Institute, The University of Sydney and the Northern Sydney Local Health District
  • 1 - 3

Datasets

Release 1.2